Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OVARIAN-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 5726 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Friis, S; Nielsen, GL; Mellemkjaer, L; McLaughlin, JK; Thulstrup, AM; Blot, WJ; Lipworth, L; Vilstrup, H; Olsen, JH
      Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study

      INTERNATIONAL JOURNAL OF CANCER
    2. Fitzpatrick, FA
      Inflammation, carcinogenesis and cancer

      INTERNATIONAL IMMUNOPHARMACOLOGY
    3. Gately, S; Kerbel, R
      Antiangiogenic scheduling of lower dose cancer chemotherapy

      CANCER JOURNAL
    4. Sundararajan, V; Grann, VR; Jacobson, JS; Ahsan, H; Neugut, AI
      Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study

      CANCER JOURNAL
    5. Howell, SB
      Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology

      CANCER JOURNAL
    6. Chandler, J; Hohenstein, P; Swing, DA; Tessarollo, L; Sharan, SK
      Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice

      GENESIS
    7. Murphy, PA
      Putting risk in perspective: An evidence-based approach to selected risks associated with the use of oral contraception

      JOURNAL OF MIDWIFERY & WOMENS HEALTH
    8. Scherr, M; LeBon, J; Castanotto, D; Cunliffe, HE; Meltzer, PS; Ganser, A; Riggs, AD; Rossi, JJ
      Detection of antisense and ribozyme accessible sites on native mRNAs: Application to NCOA3 mRNA

      MOLECULAR THERAPY
    9. Hemminki, A; Belousova, N; Zinn, KR; Liu, B; Wang, MH; Chaudhuri, TR; Rogers, BE; Buchsbaum, DJ; Siegal, GP; Barnes, MN; Gomez-Navarro, J; Curiel, DT; Alvarez, RD
      An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression

      MOLECULAR THERAPY
    10. Singh, S; Cunningham, C; Buchanan, A; Jolly, DJ; Nemunaitis, J
      Toxicity assessment of intratumoral injection of the herpes simplex type Ithymidine kinase gene delivered by retrovirus in patients with refractory cancer

      MOLECULAR THERAPY
    11. Lui, VWY; He, YK; Goyal, K; Huang, L
      Specific down-regulation of HER-2/neu mediated by a chimeric U6 hammerheadribozyme results in growth inhibition of human ovarian carcinoma

      MOLECULAR THERAPY
    12. Di Modugno, F; Buglioni, S; Mottolese, M; Del Bello, D; Cascioli, S; Chersi, A; Santoni, A; Nistico, P
      Polyclonal antibodies against gp185(HER2) peptides: Their putative role inthe identification of a particular HER2 status in patients with breast cancer

      JOURNAL OF IMMUNOTHERAPY
    13. Bluman, LG; Borstelmann, NA; Rimer, BK; Iglehart, JD; Winer, EP
      Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    14. Smith, SC; Koh, WJ
      Palliative radiation therapy for gynaecological malignancies

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    15. Stewart, DE; Rosen, B; Irvine, J; Ritvo, P; Shapiro, H; Murphy, J; Thomas, J; Robinson, GE; Neuman, J; Deber, R
      The disconnect: Infertility patients' information and the role they wish to play in decision making

      MEDSCAPE WOMENS HEALTH
    16. Holmberg, LA; Sandmaier, BM
      Theratope((R)) vaccine (STn-KLH)

      EXPERT OPINION ON BIOLOGICAL THERAPY
    17. Ostrer, H
      A genetic profile of contemporary Jewish populations

      NATURE REVIEWS GENETICS
    18. Koifman, S; Koifman, RJ
      Breast cancer mortality among Ashkenazi Jewish women in Sao Paulo and Porto Alegre, Brazil

      BREAST CANCER RESEARCH
    19. Salahshor, S; Lei, HX; Huo, HG; Kristensen, VN; Loman, N; Sjoberg-Margolin, S; Borg, A; Borresen-Dale, AL; Vorechovsky, I; Lindblom, A
      Low frequency of E-cadherin alterations in familial breast cancer

      BREAST CANCER RESEARCH
    20. Randall, J; Butow, P; Kirk, J; Tucker, K
      Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer

      INTERNAL MEDICINE JOURNAL
    21. Phillips, KA
      Current perspectives on BRCA1- and BRCA2-associated breast cancers

      INTERNAL MEDICINE JOURNAL
    22. Campos, B; Diez, O; Cortes, J; Domenech, M; Pericay, C; Alonso, C; Baiget, M
      Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    23. Magdolen, V; Burgle, M; de Prada, NA; Schmiedeberg, N; Riemer, C; Schroeck, F; Kellermann, J; Degitz, K; Wilhelm, OG; Schmitt, M; Kessler, H
      Cyclo(19,31)[D-Cys(19)]-uPA(19-31) is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)

      BIOLOGICAL CHEMISTRY
    24. Lutz, V; Reuning, U; Kruger, A; Luther, T; von Steinburg, SP; Graeff, H; Schmitt, M; Wilhelm, OG; Magdolen, V
      High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nudemice

      BIOLOGICAL CHEMISTRY
    25. Morris, SM; Cooper, JA
      Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interactswith AP-2

      TRAFFIC
    26. Kartalou, M; Essigmann, JM
      Recognition of cisplatin adducts by cellular proteins

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    27. Kartalou, M; Essigmann, JM
      Mechanisms of resistance to cisplatin

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    28. Millon, R; Muller, D; Schultz, I; Salvi, R; Ghnassia, JP; Frebourg, T; Wasylyk, B; Abecassis, J
      Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance

      ORAL ONCOLOGY
    29. Paavonen, J
      Chlamydia trachomatis and cancer

      SEXUALLY TRANSMITTED INFECTIONS
    30. Zumkeller, W
      IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    31. Martinez, A; Walker, RA; Shaw, JA; Dearing, SJ; Maher, ER; Latif, F
      Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    32. Alvi, AJ; Rader, JS; Broggini, M; Latif, F; Maher, ER
      Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    33. Vaziri, SAJ; Tubbs, RR; Darlington, G; Casey, G
      Absence of CCND 1 gene amplification in breast tumours of BRCA1 mutation carriers

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    34. Yamamoto, H; Sato, H; Shibata, S; Murata, M; Fukuda, J; Tanaka, T
      Involvement of annexin V in the antiproliferative effect of GnRH agonist on cultured human uterine leiomyoma cells

      MOLECULAR HUMAN REPRODUCTION
    35. Leamon, CP; Low, PS
      Folate-mediated targeting: from diagnostics to drug and gene delivery

      DRUG DISCOVERY TODAY
    36. Zakowski, SG; Valdimarsdottir, HB; Bovbjerg, DH
      Emotional expressivity and intrusive cognitions in women with family histories of breast cancer: Application of a cognitive processing model

      BRITISH JOURNAL OF HEALTH PSYCHOLOGY
    37. Cameron, LD; Diefenbach, MA
      Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: Influences of cancer worry and risk perceptions

      JOURNAL OF HEALTH PSYCHOLOGY
    38. Sanders, GD; Nease, RF; Owens, DK
      Publishing web-based guidelines using interactive decision models

      JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    39. Balen, A
      Polycystic ovary syndrome and cancer

      HUMAN REPRODUCTION UPDATE
    40. Kennedy, S; Bennett, S; Weeks, DE
      Genetics and infertility II - Affected sib-pair analysis in endometriosis

      HUMAN REPRODUCTION UPDATE
    41. Campbell, IG; Thomas, EJ
      Endometriosis: candidate genes

      HUMAN REPRODUCTION UPDATE
    42. Wadler, S
      New developments in the treatment of ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    43. Limonta, P; Marelli, MM; Moretti, RM
      LHRH analogues as anticancer agents: pituitary and extrapituitary sites ofaction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    44. McKeage, MJ
      Lobaplatin: a new antitumour platinum drug

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    45. Stein, RC
      Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment

      ENDOCRINE-RELATED CANCER
    46. Schneider, GP; Salcedo, R; Welniak, LA; Howard, OMZ; Murphy, WJ
      The diverse role of chemokines in tumor progression: Prospects for intervention (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    47. Behrens, P; Rothe, M; Florin, A; Wellmann, A; Wernert, N
      Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    48. Naidu, R; Wahab, NA; Yadav, M; Kutty, MK; Nair, S
      Detection of amplified int-2/FGF-3 gene in primary breast carcinomas usingdifferential polymerase chain reaction

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    49. Li, QQ; Bever, CT
      Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell lines

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    50. Harima, Y; Sawada, S; Nagata, K; Sougawa, M; Ostapenko, V; Ohnishi, T
      Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    51. Kauff, ND; Scheuer, L; Robson, ME; Glogowski, E; Kelly, B; Barakat, R; Heerdt, A; Borgen, PI; Davis, JG; Offit, K
      Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations

      GENETICS IN MEDICINE
    52. Velicer, CM; Taplin, S
      Genetic testing for breast cancer: Where are health care providers in the decision process?

      GENETICS IN MEDICINE
    53. Wittel, UA; Goel, A; Varshney, GC; Batra, SK
      Mucin antibodies - New tools in diagnosis and therapy of cancer

      FRONTIERS IN BIOSCIENCE
    54. Arver, B; Borg, A; Lindblom, A
      First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm

      GENETIC TESTING
    55. Buchsbaum, DJ; Curiel, DT
      Gene therapy for the treatment of cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    56. Noujaim, AA; Schultes, BC; Baum, RP; Madiyalakan, R
      Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13 - Evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    57. Dillman, RO; Beutel, LD; De Leon, C; Nayak, SK
      Short-term tumor cell lines from breast cancer for use as autologous tumorcell vaccines in the treatment of breast cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    58. Imam, SK
      Status of radioimmunotherapy in the new millennium

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    59. Milenic, DE; Roselli, M; Mirzadeh, S; Pippin, CG; Gansow, OA; Colcher, D; Brechbiel, MW; Schlom, J
      In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    60. Malingre, MM; Rosing, H; Koopman, FJ; Schellens, JHM; Beijnen, JH
      Performance of the analytical assays of paclitaxel, docetaxel, and cyclosporin a in a routine hospital laboratory setting

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    61. Shi, Q; Xiong, QG; Le, XD; Xie, KP
      Regulation of interleukin-8 expression by tumor-associated stress factors

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    62. Nathanson, KN; Wooster, R; Weber, BL
      Breast cancer genetics: What we know and what we need

      NATURE MEDICINE
    63. Hait, WN
      The prognostic and predictive values of ECD-HER-2

      CLINICAL CANCER RESEARCH
    64. Veal, GJ; Dias, C; Price, L; Parry, A; Errington, J; Hale, J; Pearson, ADJ; Boddy, AV; Newell, DR; Tilby, MJ
      Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy

      CLINICAL CANCER RESEARCH
    65. Zamboni, WC; D'Argenio, DZ; Stewart, CF; MacVittie, T; Delauter, BJ; Farese, AM; Potter, DM; Kubat, NM; Tubergen, D; Egorin, MJ
      Pharmacodynamic model of topotecan-induced time course of neutropenia

      CLINICAL CANCER RESEARCH
    66. Konecny, G; Untch, M; Arboleda, J; Wilson, C; Kahlert, S; Boettcher, B; Felber, M; Beryt, M; Lude, S; Hepp, H; Slamon, D; Pegram, M
      HER-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer

      CLINICAL CANCER RESEARCH
    67. Mohanam, S; Jasti, SL; Kondraganti, SR; Chandrasekar, N; Kin, Y; Fuller, GN; Lakka, SS; Kyritsis, AP; Dinh, DH; Olivero, WC; Gujrati, M; Yung, WKA; Rao, JS
      Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells

      CLINICAL CANCER RESEARCH
    68. Vaziri, SAJ; Krumroy, LM; Elson, P; Budd, GT; Darlington, G; Myles, J; Tubbs, RR; Casey, G
      Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis

      CLINICAL CANCER RESEARCH
    69. Rose, WC; Long, BH; Fairchild, CR; Lee, FYF; Kadow, JF
      Preclinical pharmacology of BMS-275183, an orally active taxane

      CLINICAL CANCER RESEARCH
    70. Kohn, EC; Reed, E; Sarosy, GA; Minasian, L; Bauer, KS; Bostick-Bruton, F; Kulpa, V; Fuse, E; Tompkins, A; Noone, M; Goldspiel, B; Pluda, J; Figg, WD; Liotta, LA
      A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solidtumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction

      CLINICAL CANCER RESEARCH
    71. Advani, R; Fisher, GA; Lum, BL; Hausdorff, J; Halsey, J; Litchman, M; Sikic, BI
      A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance

      CLINICAL CANCER RESEARCH
    72. Alberts, DS; Hallum, AV; Stratton-Custis, M; Garcia, DJ; Gleason-Guzman, M; Salmon, SE; Santabarbara, P; Niesor, EJ; Floret, S; Bentzen, CL
      Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug

      CLINICAL CANCER RESEARCH
    73. Doolittle, ND; Muldoon, LL; Brummett, RE; Tyson, RM; Lacy, C; Bubalo, JS; Kraemer, DF; Heinrich, MC; Henry, JA; Neuwelt, EA
      Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors

      CLINICAL CANCER RESEARCH
    74. Griffin, GM; Zhu, T; Solonenko, M; Del Piero, F; Kapakin, A; Busch, TM; Yodh, A; Polin, G; Bauer, T; Fraker, D; Hahn, SM
      Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model

      CLINICAL CANCER RESEARCH
    75. Omura-Minamisawa, M; Diccianni, MB; Chang, RC; Batova, A; Bridgeman, LJ; Schiff, J; Cohn, SL; London, WB; Yu, AL
      p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease

      CLINICAL CANCER RESEARCH
    76. Kuang, J; He, GG; Huang, ZF; Khokhar, AR; Siddik, ZH
      Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints

      CLINICAL CANCER RESEARCH
    77. Lyass, O; Hubert, A; Gabizon, AA
      Phase I study of doxil-cisplatin combination chemotherapy in patients withadvanced malignancies

      CLINICAL CANCER RESEARCH
    78. Ferguson, WS; Harris, MB; Goorin, AM; Gebhardt, MC; Link, MP; Shochat, SJ; Siegal, GP; Devidas, M; Grier, HE
      Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group trial

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    79. Koh, SCL; Tham, KF; Razvi, K; Oei, PL; Lim, FK; Roy, AC; Prasad, RNV
      Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included asprognostic markers for survival outcome?

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    80. Williams, RS; Green, R; Glover, JNM
      Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1

      NATURE STRUCTURAL BIOLOGY
    81. Ursic-Vrscaj, M; Bebar, S; Zakelj, MP
      Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival

      MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
    82. Sawasaki, T; Shigemasa, K; Shiroyama, Y; Kusuda, T; Fujii, T; Parmley, TH; O'Brien, TJ; Ohama, K
      Cyclin E mRNA overexpression in epithelial ovarian cancers: Inverse correlation with p53 protein accumulation

      JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    83. Havrilesky, LJ; McMahon, CP; Lobenhofer, EK; Whitaker, R; Marks, JR; Berchuck, A
      Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones

      JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    84. Xu, Y; Xiao, YJ; Baudhuin, LM; Schwartz, BM
      The role and clinical applications of bioactive lysolipids in ovarian cancer

      JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    85. Lagana, L; McGarvey, EL; Classen, C; Koopman, C
      Psychosexual dysfunction among gynecological cancer survivors

      JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS
    86. Blair, SL; Chu, DZJ; Schwarz, RE
      Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer

      ANNALS OF SURGICAL ONCOLOGY
    87. Newman, LA; Kuerer, HM; Hunt, KK; Vlastos, G; Ames, FC; Ross, MI; Singletary, SE
      Educational review: Role of the surgeon in hereditary breast cancer

      ANNALS OF SURGICAL ONCOLOGY
    88. McCarter, MD; Fong, YM
      Role for surgical cytoreduction in multimodality treatments for cancer

      ANNALS OF SURGICAL ONCOLOGY
    89. Hendren, SK; Hahn, SM; Spitz, FR; Bauer, TW; Rubin, SC; Zhu, T; Glatstein, E; Fraker, DL
      Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors

      ANNALS OF SURGICAL ONCOLOGY
    90. Jennings, PK; Callahan, JC
      Multiple gestations: Some public policy issues

      HEALTH CARE ANALYSIS
    91. Zenklusen, JC; Conti, CJ; Green, ED
      Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31

      NATURE GENETICS
    92. Jakubowska, A; Gorski, B; Byrski, T; Huzarski, T; Gronwald, J; Menkiszak, J; Cybulski, C; Debniak, T; Hadaczek, P; Scott, RJ; Lubinski, J
      Detection of germline mutations in the BRCA1 gene by RNA-based sequencing

      HUMAN MUTATION
    93. Edwards, SM; Kote-Jarai, Z; Hamoudi, R; Eeles, RA
      An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations - Fluorescent mutation detection (F-MD)

      HUMAN MUTATION
    94. Chang, CC; Hsieh, YY; Chung, JG; Tsai, HD; Tsai, CH
      Kinetics of acetyl coenzyme A: Arylamine N-acetyltransferase from human cumulus cells

      JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
    95. Tercyak, KP; Peshkin, BN; Streisand, R; Lerman, C
      Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants

      PSYCHO-ONCOLOGY
    96. Satagopan, JM; Offit, K; Foulkes, W; Robson, ME; Wacholder, S; Eng, CM; Karp, SE; Begg, CB
      The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    97. Lawrence, WF; Peshkin, BN; Liang, WC; Isaacs, C; Lerman, C; Mandelblatt, JS
      Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    98. Pauler, DK; Menon, U; McIntosh, M; Symecko, HL; Skates, SJ; Jacobs, IJ
      Factors influencing serum CA125II levels in healthy postmenopausal women

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    99. Couch, FJ; Cerhan, JR; Vierkant, RA; Grabrick, DM; Therneau, TM; Pankratz, VS; Hartmann, LC; Olson, JE; Vachon, CM; Sellers, TA
      Cigarette smoking increases risk for breast cancer in high-risk breast cancer families

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    100. Baron, AT; Lafkyk, JM; Suman, VJ; Hillman, DW; Buenafe, MC; Boardman, CH; Podratz, KC; Perez, EA; Maihle, NJ
      A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/04/14 alle ore 10:25:48